Trials always continue past the point where FDA has enough data for approval submissions. Further, there’s commonly a primary study end date and a final study end date, indicating when primary effects will be monitored until and when secondary effects and adverse events will be monitored until.
Pfizer and Moderna already have enough trial data to file for full FDA approval. Pfizer is doing so this month. Moderna will file shortly after. Both are getting priority review. No data is working against them, so both should see full approvals by the end of summer or early fall.
Are you troubled by the fact that no genotoxicity studies are being done on the mRVA vaxxes?
Well of course they do. They've had millions of unknowing trial participants. The general public.
Will that make them liable for adverse reactions?
And we’ll end up with a Ford Pinto!